SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Munshi Amit

(Last) (First) (Middle)
4225 EXECUTIVE SQUARE,
SUITE 600

(Street)
LA JOLLA CA 92037

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/20/2023
3. Issuer Name and Ticker or Trading Symbol
Zura Bio Ltd [ ZURA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares 499,993(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Share Option (Right to Buy) (2) 03/20/2033 Class A Ordinary Shares 306,373 $8.16 D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units on March 18, 2023, which shall vest in four equal, annual installments, beginning on March 18, 2024, subject to the Reporting Person's continuous employment with the Issuer.
2. The Reporting Person was granted on March 20, 2023 the option to purchase Issuer Class A Ordinary Shares at an exercise price per ordinary share equal to the fair market value of a Class A Ordinary Share at the date of grant, which will become exercisable if the volume weighted average price of the Issuer's Class A Ordinary Shares over twenty trading days is over $30 per Class A Ordinary Share at any time prior to March 20, 2028, subject to the Reporting Person remaining as Non-Executive Chairman of the Board of Directors of the Issuer.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kimberly Ann Davis, Attorney-in-Fact 03/21/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.